ABSTRACT
Background Diabetes is a serious medical condition marked by high blood sugar levels, leading to complications in organs like the kidney, liver, and heart. Previous research has identified diabetes as a primary risk factor for congestive heart failure (CHF), a condition where stiffened heart muscles hinder oxygenated blood circulation. Despite its severity, few studies have examined CHF prognosis in diabetic patients. This study aims to provide survival estimates and provide their comparisons among predictors, assess mortality risks based on specific variables, and reveal patient outcome patterns.
Methods We analyzed data from a 2015 study at Faisalabad Institute of Cardiology and Allied Hospital (FICAH), Pakistan, focusing on 125 diabetic patients with Class III or IV heart failure and left ventricular systolic dysfunction. Kaplan-Meier estimates provided survival rates, log-rank tests compared survival across variables, Cox regression models estimated hazard ratios, and cluster analysis grouped patients by characteristics and survival rates.
Results The study examined 125 diabetic heart failure patients. Of these, 40(32%) were censored and the remaining 85(68%) died. The total follow-up period was 278 days, on the 120th day, 0.752[95% CI = 0.678,0,883] of the patients survived after initial diagnosis. Log-rank tests showed survival differences linked to high blood pressure, anemia and smoking. Cox regression identified age, smoking and hypertension as major mortality risk factors. Cluster analysis revealed the risk factors associated with middle aged and the older patients.
Conclusion The overall prognosis of heart failure patients with diabetes was poor with high mortality rates, implying effective treatment and management.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
this study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Humanities and Social Science Research Ethics Committee of Kwame Nkrumah University of Science and Technology waived ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
List of abbreviations
- CHF
- Congestive Heart Failure
- HF
- Heart Failure
- CI
- Confidence Interval
- HR
- Hazard Ratio
